Bioflamex Corp. (BFLX) Financials Nov 14, 2014, 8:10

Bioflamex Corp. (BFLX) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Bioflamex Corp.


Fiscal year is March-February. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 500 500 0 0 0
COGS excluding D&A 500 500 0 0 0
Depreciation & Amortization Expense 0 0 0 0 -
Depreciation 0 0 0 0 0
Amortization of Intangibles 0 - - - -
Gross Income (500) (500) 0 0 0
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 80 44,742 1.65M 779,916 143,220
Research & Development 0 0 0 0 -
Other SG&A 80 44,742 1.65M 779,916 143,220
Other Operating Expense 11,861 135 0 0 0
Unusual Expense 0 0 0 400,000 19,817
EBIT after Unusual Expense 0 0 0 (400,000) (19,817)
Non Operating Income/Expense 0 0 337 192 0
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 0 - 5,602 194,217 9,479
Gross Interest Expense 0 - 5,602 194,217 9,479
Interest Capitalized 0 0 0 0 0
Pretax Income (12,441) (45,377) (1.65M) (1.37M) (172,516)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 0 0
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic 0 0 0 0 0
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income (12,441) (45,377) (1.65M) (1.37M) (172,516)
Minority Interest Expense 0 0 0 0 0
Net Income (12,441) (45,377) (1.65M) (1.37M) (172,516)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (12,441) (45,377) (1.65M) (1.37M) (172,516)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (12,441) (45,377) (1.65M) (1.37M) (172,516)
EPS (Basic) () () (0.68) (0.33) 0.00
Basic Shares Outstanding 3.25M 3.17M 2.41M 4.18M 8.87B
EPS (Diluted) () () (0.68) (0.33) 0.00
Diluted Shares Outstanding 3.25M 3.17M 2.41M 4.18M 8.87B
EBITDA (12,441) (45,377) (1.65M) (779,916) (143,220)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.